Medicine
Zinplava 1000 mg/40 mL injection
Zinplava 1000 mg/40 mL injection is a prescription medicine containing Bezlotoxumab for intravenous use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in a refrigerator, 2ºC to 8ºC (36ºF to 46ºF) in original carton to…
Key facts
- Active ingredient (INN)
- Bezlotoxumab
- Brand
- Zinplava
- Strength
- 1000 mg/40 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 40 mL
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturer
- Merck Sharp & Dohme
- Origin register
- US FDA, United States
- Storage
- Store in a refrigerator, 2ºC to 8ºC (36ºF to 46ºF) in original carton to protect from light. Do Not Freeze. Do Not Shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J06BB21 Bezlotoxumab
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 October 2016
- Identifiers
- RxCUI 1855052, 1855057DailyMed set ID 8f479bfe-2bfa-4cc5-9aee-1357364480b0NDC 0006-3025Application BLA761046
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 40 mL in 1 vial, single-dose | 0006-3025-00 | Merck Sharp & Dohme | 21 October 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Bezlotoxumab is a prescription medicine indicated to reduce recurrence of Clostridioides difficile infection (CDI) in adults and pediatric patients 1 year of age and older, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Bezlotoxumab for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BezlotoxumabFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ZINPLAVA prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
Need Zinplava 1000 mg/40 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.